Review of goal attainment scaling as a useful outcome measure in psychogeriatric patients with cognitive disorders

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 6, 2008, Pages 528-540

  Bouwens, Sharon F M ^a   Van Heugten, Caroline M ^a,c   Verhey, Frans R J ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinimetrics; Daily life activities; Ecological validity; Everyday functioning; Feasibility; Individualized approach

Indexed keywords

DONEPEZIL; GALANTAMINE; LINOPIRDINE;

ALZHEIMER DISEASE; CAREGIVER; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTRUCT VALIDITY; CONTENT VALIDITY; GERONTOPSYCHIATRY; GOAL ATTAINMENT; HUMAN; INTERRATER RELIABILITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECREATIONAL THERAPY; REVIEW;

AGED; COGNITION DISORDERS; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; GOALS; HUMANS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 57049151302     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000178757     Document Type: Review

References (68)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1995.
2. Beswick AD, Rees K, Dieppe P, Ayis S, Gooberman-Hill R, Horwood J, et al: Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis. Lancet 2008;371:725-735.
3. Boothroyd RA, Banks SM: Assessing outcomes in individually-tailored interventions. Lancet 2006;367:801-802.
4. Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E: International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Int Psychogeriatr 2007;19:345-354.
5. Gauthier S: Cholinesterase inhibitors in late-stage Alzheimer's disease. Lancet Neurol 2006;5:468-469.
6. Hogan DB: Donepezil for severe Alzheimer's disease. Lancet 2006;367:1031-1032.
7. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
8. Harrison JE: Measuring cognitive change in Alzheimer's disease clinical drug trials. J Nutr Health Aging 2007;11:327-329.
9. Kiresuk T, Sherman RE: Goal Attainment Scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J 1968;4:443-453.
10. Malec JF: Goal Attainment Scaling in rehabilitation. Neuropsychol Rehabil 1999;9:253-275.
11. Joyce BM, Rockwood KJ, Mate-Kole CC: Use of Goal Attainment Scaling in brain injury in a rehabilitation hospital. Am J Phys Med Rehabil 1994;73:10-14.
12. Fisher K: Assessing clinically meaningful change following a programme for managing chronic pain. Clin Rehabil 2008;22:252-259.
13. World Health Organization: ICIDH-2: International Classification of Functioning, Disability, and Health - Final draft. Madrid, WHO, 2001.
14. Bravo G, Dubois MF, Roy PM: Using Goal Attainment Scaling to improve the quality of long-term care: a group-randomized trial. Int J Qual Health Care 2005;17:511-519.
15. Rockwood K, Fay S, Jarrett P, Asp E: Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial. Neurology 2007;68:1116-1121.
16. Yau DCN, Lam MCC, Lung MKW, Chow AYH, Yung NSY, Chui TY, et al: Outcomefocused nursing practice in geriatric day-rehabilitation service: facilitating elderly patients to achieve therapeutic goals. Hong Kong Nurs J 2002;38:33-38.
17. AD2000 Collaborative Group: Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double blind trial. Lancet 2004;363:2105-2115.
18. Malec JF, Smigielski JS, DePompolo RW: Goal Attainment Scaling and outcome measurement in postacute brain injury rehabilitation. Arch Phys Med Rehabil 1991;72:138-143.
19. Gordon JE, Powell C, Rockwood K: Goal Attainment Scaling as a measure of clinically important change in nursing-home patients. Age Ageing 1999;28:275-281.
20. van Tulder MW, Assendelft WJ, Koes BW, Bouter LM: Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders. Spine 1997;22:2323-2330.
21. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM: On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003;12:349-362.
22. Badia X, Podzamczer D, Casado A, Lopez-Lavid C, Garcia M: Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV Validation Group. Aids 2000;14:1439-1447.
23. Norman GR: Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989;42:1097-1105.
24. Kazis LE, Anderson JJ, Meenan RF: Effect sizes for interpreting changes in health status. Med Care 1989;27:S178-S189.
25. Liang MH, Fossel AH, Larson MG: Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28:632-642.
26. Liang MH, Larson MG, Cullen KE: Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542-547.
27. Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, Erlbaum, 1988.
28. Faraone SV: Understanding effect size: how it's measured and what it means. Medscape Psychiatry & Mental Health, 2008.
29. Angst F, Goldhahn J, Drerup S, Aeschlimann A, Schwyzer HK, Simmen BR: Responsiveness of six outcome assessment instruments in total shoulder arthroplasty. Arthritis Rheum 2008;59:391-398.
30. Heiman GW: Research Methods in Psychology. Boston, Houghton Mifflin, 1999.
31. Hinkle DE, Wiersma W, Jurs SG: Applied statistics for the behavioral sciences. New York, Houghton Mifflin, 1998.
32. Hartman D, Borrie MJ, Davison E, Stolee P: Use of Goal Attainment Scaling in a dementia special care unit. Am J Alzheimers Dis Other Demen 1997;12:111-116.
33. Rockwood K, Fay S, Song X, MacKnight C, Gorman M: Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial. CMAJ 2006;174:1099-1105.
34. Rockwood K, Graham JE, Fay S: Goal setting and attainment in Alzheimer's disease patients treated with donepezil. J Neurol Neurosurg Psychiatry 2002;73:500-507.
35. Rockwood K, Howlett S, Stadnyk K, Carver D, Powell C, Stolee P: Responsiveness of Goal Attainment Scaling in a randomized controlled trial of comprehensive geriatric assessment. J Clin Epidemiol 2003;56:736-743.
36. Rockwood K, Stolee P, Fox RA: Use of Goal Attainment Scaling in measuring clinically important change in the frail elderly. J Clin Epidemiol 1993;46:1113-1118.
37. Rockwood K, Stolee P, Howard K, Mallery L: Use of Goal Attainment Scaling to measure treatment effects in an anti-dementia drug trial. Neuroepidemiology 1996;15:330-338.
38. Stolee P, Rockwood K, Fox RA, Streiner DL: The use of Goal Attainment Scaling in a geriatric care setting. J Am Geriatr Soc 1992;40:574-578.
39. Stolee P, Stadnyk K, Myers AM, Rockwood K: An individualized approach to outcome measurement in geriatric rehabilitation. J Gerontol A Biol Sci Med Sci 1999;54:M641-M647.
40. Yip AM, Gorman MC, Stadnyk K, Mills WG, MacPherson KM, Rockwood K: A standardized menu for Goal Attainment Scaling in the care of frail elders. Gerontologist 1998;38:735-742.
41. Fox RA, Clarfield AM, Hogan DB: Competencies required for the practice of geriatric medicine as a consultant physician. CMAJ 1989;141:1045-1048.
42. Rubenstein LV, Calkins DR, Greenfield S, Jette AM, Meenan RF, Nevins MA, et al: Health status assessment for elderly patients. Report of the Society of General Internal Medicine Task Force on Health Assessment. J Am Geriatr Soc 1989;37:562-569.
43. Rubenstein LZ: Comprehensive geriatric assessment. Ann Intern Med 1988;108:724-727.
44. Stolee P, Zaza C, Pedlar A, Myers AM: Clinical experience with Goal Attainment Scaling in geriatric care. J Aging Health 1999;11:96-124.
45. Asp E, Cloutier F, Fay S, Cook C, Robertson ML, Fisk J, et al: Verbal repetition in patients with Alzheimer's disease who receive donepezil. Int J Geriatr Psychiatry 2006;21:426-431.
46. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428.
47. Ottenbacher KJ, Cusick A: Discriminative versus evaluative assessment: some observations on Goal Attainment Scaling. Am J Occup Ther 1993;47:349-354.
48. Donnelly C, Carswell A: Individualized outcome measures: a review of the literature. Can J Occup Ther 2002;69:84-94.
49. Knopman DS, Knapp MJ, Gracon SI, Davis CS: The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease. Neurology 1994;44:2315-2321.
50. Bouwens SF, van Heugten CM, Aalten P, Wolfs CA, Baarends EM, van Menxel DA, et al: Relationship between measures of dementia severity and observation of daily life functioning as measured with the Assessment of Motor and Process Skills (AMPS). Dement Geriatr Cogn Disord 2008;25:81-87.
51. de Vugt ME, Stevens F, Aalten P, Lousberg R, Jaspers N, Winkens I, et al: Behavioural disturbances in dementia patients and quality of the marital relationship. Int J Geriatr Psychiatry 2003;18:149-154.
52. Ponsford J, Olver J, Nelms R, Curran C, Ponsford M: Outcome measurement in an inpatient and outpatient traumatic brain injury rehabilitation programme. Neuropsychol Rehabil 1999;9:517-534.
53. Reisberg B, Ferris SH: Brief Cognitive Rating Scale (BCRS). Psychopharmacol Bull 1988;24:629-636.
54. Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J 1965;14:61-65.
55. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA: Cornell Scale for Depression in Dementia. Biol Psychiatry 1988;23:271-284.
56. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
57. Parmelee PA, Thuras PD, Katz IR, Lawton MP: Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 1995;43:130-137.
58. Pfeffer RI, Kurosaki TT, Harrach CH, Chance JM, Filos S: Measurement of functional activities in older adults in the community. J Gerontol 1982;37:232-329.
59. Guide for the Use of the Functional Independence Measure. Uniform Data System for Medical Rehabilitation. Buffalo, State University of New York at Buffallo, 1987.
60. Reisberg B, Ferris SH, de Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
61. MacKnight C, Rockwood K: A hierarchical assessment of balance and mobility. Age Ageing 1995;24:126-130.
62. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
63. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
64. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
65. Hunt SM, McEwan J, McKenna SP: Measuring Health Status. London, Croom Helm, 1986.
66. George LK, Fillenbaum GG: OARS methodology. A decade of experience in geriatric assessment. J Am Geriatr Soc 1985;33:607-615.
67. Molloy DW, Alemayehu E, Roberts R: Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psychiatry 1991;148:102-105.
68. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, et al: Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 1981;34:585-597.